Atrevia® 360° wins the Preventative Pet Care Product of the Year 2025 by the prestigious Pet Innovation Awards, an independent recognition platform that highlights the most innovative companies, services, and products in the pet care industry. The award was celebrated in Los Angeles, USA.

Atrevia® 360, as the newest innovation in the Petmedica® portfolio, is a chewable tablet that provides exclusive, long-lasting, and simultaneous protection for dogs against external parasites (fleas, ticks, and mites) and internal parasites, including heartworm, gastrointestinal and pulmonary nematodes, as well as cestodes (tapeworms). Formulated with praziquantel, Atrevia® 360° eliminates all relevant canine tapeworm species, such as Echinococcus granulosus and Dipylidium caninum.

Petmedica® announces the launch of Suralan®, a new ectoparasitic treatment product designed exclusively for dogs, which promises an excellent solution for the control of fleas, ticks and mites, formulated with sarolaner.

Suralan® is a pleasant tasting soft chewable tablet that has been specially formulated to provide dogs with an effective and easy to administer treatment. Sarolaner, an ultra-purified active ingredient, is known for its systemic action and for being a potent and effective treatment against ectoparasite infestations. Thanks to its enantiomeric form, in particular the chirally pure S enantiomer present in its composition, Suralan® achieves a superior pharmacological action, using a lower amount of active ingredient.

Petmedica® was present at the 4th edition of the year of Latin in your City, an event that took place in the city of Arequipa, on Saturday, October 26 and Sunday, October 27 at the facilities of Hotel Tierra Sur.